{"id":"CVE-2017-17678","published":"2021-05-19T13:11:01Z","modified":"2026-07-09T00:09:21Z","title":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS)","vendor":null,"product":null,"tier":"tail","description":{"text":"BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.","provenance":"source","from":"CVE.org"},"cvss":null,"epss":{"score":0.00591,"percentile":0.48991,"provenance":"source"},"cwes":[],"references":[{"url":"https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html","tags":[]},{"url":"https://seclists.org/fulldisclosure/2017/Oct/52","tags":[]}],"priority":{"score":9.8,"factors":[{"name":"EPSS percentile","points":9.8}]},"euvd":{"id":"EUVD-2017-8835","exploited":false,"provenance":"source"}}